Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease: Primary Clinical Results of the ACADEMIC Study
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background — Chlamydia pneumoniae is associated with coronary artery disease (CAD), although its causal role is uncertain. A small preliminary study reported a >50% reduction in ischemic events by azithromycin, an antibiotic effective against C pneumoniae , in seropositive CAD patients. We tested this prospectively in a larger, randomized, double-blind study. Methods and Results —CAD patients (n=302) seropositive to C pneumoniae (IgG titers ≥1:16) were randomized to placebo or azithromycin 500 mg/d for 3 days and then 500 mg/wk for 3 months. The primary clinical end point included cardiovascular death, resuscitated cardiac arrest, nonfatal myocardial infarction (MI), stroke, unstable angina, and unplanned coronary revascularization at 2 years. Treatment groups were balanced, and azithromycin was generally well tolerated. During the trial, 47 first primary events occurred (cardiovascular death, 9; resuscitated cardiac arrest, 1; MI, 11; stroke, 3; unstable angina, 4; and unplanned coronary revascularization, 19), with 22 events in the azithromycin group and 25 in the placebo group. There was no significant difference in the 1 primary end point between the 2 groups (hazard ratio for azithromycin, 0.89; 95% CI, 0.51 to 1.61; P =0.74). Events included 9 versus 7 occurring within 6 months and 13 versus 18 between 6 and 24 months in the azithromycin and placebo groups, respectively. Conclusions —This study suggests that antibiotic therapy with azithromycin is not associated with marked early reductions (≥50%) in ischemic events as suggested by an initial published report. However, a clinically worthwhile benefit (ie, 20% to 30%) is still possible, although it may be delayed. Larger (several thousand patient), longer-term (≥3 to 5 years) antibiotic studies are therefore indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Saikku, P., Mattila, K., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,964
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Cell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003 · cited 1×
“Pathophysiological Considerations Our results are consistent with 3 possibilities: (1) a noncausal role of C pneumoniaein CAD pathogenesis, (2) a smaller benefit for antibiotic therapy (eg, 20% to 30% beneficial effect), or (3) a causal role for C pneumoniaewith the present negative results explained by inefficiency o…”
ResultSaikku, P., Leinonen, M., Tenkanen, L., Linnanmäki, E., Ekman, M.-R., Manninen, V., Mänttäri, M., Frick, M. H., & Huttunen, J. K. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-273 · Cited by 786
Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries
Kuo, C.-C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L., & Grayston, J. T. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.4.841 · Cited by 762
A New Chlamydia psittaci Strain, TWAR, Isolated in Acute Respiratory Tract Infections
Grayston, J. T., Kuo, C.-C., Wang, S.-P., & Altman, J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607173150305 · Cited by 718
Gupta, S., Leatham, E. W., Carrington, D., Mendall, M. A., Kaski, J. C., & Camm, A. J. (1997) · Circulation · doi:10.1161/01.cir.96.2.404 · Cited by 706
Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study
Gurfinkel, E., Bozovich, G., Daroca, A., Beck, E., & Mautner, B. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07201-2 · Cited by 573
Libby, P., Egan, D., & Skarlatos, S. (1997) · Circulation · doi:10.1161/01.cir.96.11.4095 · Cited by 556
Kol, A., Sukhova, G. K., Lichtman, A. H., & Libby, P. (1998) · Circulation · doi:10.1161/01.cir.98.4.300 · Cited by 538
Muhlestein, J. B., Anderson, J. L., Hammond, E. H., Zhao, L., Trehan, S., Schwobe, E. P., & Carlquist, J. F. (1998) · Circulation · doi:10.1161/01.cir.97.7.633 · Cited by 517
Self-citationKol, A., Bourcier, T., Lichtman, A. H., & Libby, P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5310 · Cited by 510
Ramirez, J. A., & Chlamydia pneumoniae/Atherosclerosis Study Group* (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00008 · Cited by 478
Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.
Shor, A., Kuo, C. C., & Patton, D. L. (1992) · PubMed · Cited by 455
Gaydos, C. A., Summersgill, J. T., Sahney, N. N., Ramirez, J. A., & Quinn, T. C. (1996) · Infection and Immunity · doi:10.1128/iai.64.5.1614-1620.1996 · Cited by 442
Muhlestein, J. B., Hammond, E. H., Carlquist, J. F., Radicke, E., Thomson, M. J., Karagounis, L. A., Woods, M. L., & Anderson, J. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00055-1 · Cited by 420
Self-citationThom, D. H. (1992) · JAMA · doi:10.1001/jama.268.1.68 · Cited by 397
The Treatment of Helicobacter pylori Infection in the Management of Peptic Ulcer Disease
Walsh, J. H., & Peterson, W. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331508 · Cited by 383
Infections Caused by Chlamydia pneumoniae Strain TWAR
Grayston, J. T. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.5.757 · Cited by 372
Anderson, J. L., Muhlestein, J. B., Carlquist, J., Allen, A., Trehan, S., Nielson, C., Hall, S., Brady, J., Egger, M., Horne, B., et al. (1999) · Circulation · doi:10.1161/01.cir.99.12.1540 · Cited by 335
Self-citationChlamydia pneumoniae (TWAR) in Atherosclerosis of the Carotid Artery
Grayston, J. T., Kuo, C.-C., Coulson, A. S., Campbell, L. A., Lawrence, R. D., Lee, M. J., Strandness, E. D., & Wang, S.-P. (1995) · Circulation · doi:10.1161/01.cir.92.12.3397 · Cited by 333
Thom, D. H. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490010070032 · Cited by 316
Gurfinkel, E. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1283 · Cited by 304
Linnanmäki, E., Leinonen, M., Mattila, K., Nieminen, M. S., Valtonen, V, & Saikku, P. (1993) · Circulation · doi:10.1161/01.cir.87.4.1130 · Cited by 283
Induction of Macrophage Foam Cell Formation by Chlamydia pneumoniae
Kalayoglu, M. V., & Byrne, G. I. (1998) · The Journal of Infectious Diseases · doi:10.1086/514241 · Cited by 275
Rabbit model for Chlamydia pneumoniae infection
Fong, I. W., Chiu, B., Viira, E., Fong, M. W., Jang, D., & Mahony, J. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.48-52.1997 · Cited by 258
Anderson, J. L., Carlquist, J. F., Muhlestein, J. B., Horne, B. D., & Elmer, S. P. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00203-4 · Cited by 229
Self-citationUdelsman, R., Blake, M. J., Stagg, C. A., Li, D. G., Putney, D. J., & Holbrook, N. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116224 · Cited by 215
Cytomegalovirus DNA in arterial walls of patients with atherosclerosis
Melnick, J. L., Hu, C., Burek, J., Adam, E., & Debakey, M. E. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890420213 · Cited by 189
Kalayoglu, M. V., & Byrne, G. I. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5067-5072.1998 · Cited by 188
In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)
Chirgwin, K., Roblin, P. M., & Hammerschlag, M. R. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1634 · Cited by 90
Cited by
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Lockhart, P. B., Bolger, A. F., Papapanou, P. N., Osinbowale, O., Trevisan, M., Levison, M. E., Taubert, K. A., Newburger, J. W., Gornik, H. L., Gewitz, M. H., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31825719f3 · Cited by 1,038
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.163 · Cited by 373
Anti-inflammatory effects of macrolide antibiotics
Čulić, O., Eraković, V., & Parnham, M. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01321-8 · Cited by 334
Metadata
- Authors
- Muhlestein, J. B., Anderson, J. L., Carlquist, J. F., Salunkhe, K., Horne, B. D., Pearson, R. R., Bunch, T. J., Allen, A., Trehan, S., & Nielson, C.
- Venue
- Circulation
- Published
- 2000-10-10
- Volume
- 102
- Issue
- 15
- Pages
- 1755-1760
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2033866501
- Cited by
- 207
- References
- 32
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.